The Convalescent Plasma Craze! Where Does India Stand?

Journal of Laboratory Physicians

Subramanian Arulselvi¹  Arcot J. Priyadarsini²  Kumar Karan² 

[1] Department of Laboratory Medicine & Blood Bank, Jai Prakash Narayan Apex Trauma Centre, New Delhi, India;Department of Transfusion Medicine, AIIMS, New Delhi, India;

关键词: covid-19;    convalescent plasma;    india;    challenges;   

DOI  :  10.1055/s-0041-1730753

来源: DOAJ

【 摘 要 】

India becomes the country with second highest number of coronavirus disease 2019 (COVID-19) cases (59,03,932) as of September 2020. As the world debates various treatment options, the current pandemic has led to the resurgence of an ancient technique, namely convalescent plasma therapy. Although it has been in use from the late 19th century, it is an uncharted territory for most developing nations. In this article, we have discussed the pros and cons of convalescent plasma transfusion in COVID-19 patients. Articles discussed in this review have been obtained from search engines, namely PubMed, Scopus, and Embase. We have also expressed our viewpoint on the feasibility and logistical challenges of convalescent plasma use in India.

【 授权许可】

Unknown